banner add

Regulators Approve Lenacapavir for H.I.V. Prevention

The drug could change the course of the AIDS epidemic. But the Trump administration has gutted the programs that might have paid for it in low-income countries.

from NYT > Health https://ift.tt/y2nkZ4Y
via IFTTT

No comments

Moderna’s Shift to Cancer Company Lifts Stock Up 177%

The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else. from NYT > Health...

Theme images by PLAINVIEW. Powered by Blogger.